Pan-tumor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| ONO-4538 Phase II Rollover Study (ONO-4538-98) (NCT04566380) | Ono Pharmaceutical Co., Ltd. | 2020-09-10 |
| A Study of Nivolumab Combined With Ipilimumab and Nivolumab Alone in Patients With Advanced or Metastatic Solid Tumors of High Tumor Mutational Burden (TMB-H) (NCT03668119) | Bristol-Myers Squibb | 2018-10-31 |
Track Pan-tumor automatically
Every clearance here is in the API, with alerts when new ones post.